ArticleMolecular imaging and biology2025

Preclinical Evaluation of an Anti-EphA2 Minibody-Based ImmunoPET Agent as a Diagnostic Tool For Cancer.

Peggy A Birikorang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.